{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:46:32Z","timestamp":1793195192711,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"am","delay-in-days":508,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Research and Development Committee (FoU-kommitt\u00e9n) at the Central Hospital Kristianstad, Sweden"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.02.026","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T00:52:28Z","timestamp":1424479948000},"page":"1688-1694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals"],"prefix":"10.1016","volume":"33","author":[{"given":"Per","family":"Nived","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Sv\u00e6rke","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Settergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.02.026_bib0140","first-page":"1404","article-title":"[29-year-old man treated with splenectomy died of pneumococcal sepsis. Important that pneumococcal vaccination of splenectomised is not forgotten]","volume":"109","author":"Werner","year":"2012","journal-title":"Lakartidningen"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0145","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/bjs.1800780904","article-title":"Postsplenectomy sepsis and its mortality rate: actual versus perceived risks","volume":"78","author":"Holdsworth","year":"1991","journal-title":"Br J Surg"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0150","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1198-743x.2001.00355.x","article-title":"Prevention and management of infections in patients without a spleen","volume":"7","author":"Davidson","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bjs.6106","article-title":"Vaccination of asplenic or hyposplenic adults","volume":"95","author":"Mourtzoukou","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0160","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jama.281.3.243","article-title":"Safety of revaccination with pneumococcal polysaccharide vaccine","volume":"281","author":"Jackson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/428135","article-title":"Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine","volume":"191","author":"Musher","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0175","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.65.5.535","article-title":"Persistence of antibodies in human subjects injected with pneumococcal polysaccharides","volume":"65","author":"Heidelberger","year":"1950","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O\u2019Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0190","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0195","unstructured":"SOSFS 1994:26 Vaccination mot pneumokocker n.d. (Regulation from the National Board of Health and Welfare, Sweden) http:\/\/www.socialstyrelsen.se\/publikationer1994\/1994-10-26 (accessed January 17, 2015)."},{"key":"10.1016\/j.vaccine.2015.02.026_bib0200","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM197710272971701","article-title":"Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy","volume":"297","author":"Ammann","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0205","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00005373-199805000-00004","article-title":"Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy","volume":"44","author":"Shatz","year":"1998","journal-title":"J Trauma"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10096-008-0523-5","article-title":"Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children","volume":"27","author":"Mikoluc","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4161\/hv.5.2.6557","article-title":"Immune response to pneumococcal conjugate vaccination in asplenic individuals","volume":"5","author":"Stanford","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jim.2004.11.006","article-title":"Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes","volume":"296","author":"Lal","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jiph.2011.06.004","article-title":"Adherence to preventive measures after splenectomy in the hospital setting and in the community","volume":"4","author":"Coignard-Biehler","year":"2011","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10096-009-0870-x","article-title":"Management of post-splenectomy patients in the Netherlands","volume":"29","author":"Lammers","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0235","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0264-410X(01)00347-4","article-title":"Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and\/or 23-valent polysaccharide vaccine among HIV-infected adults","volume":"20","author":"Feikin","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0240","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/656147","article-title":"A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults","volume":"202","author":"Crum-Cianflone","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0245","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e3282887e91","article-title":"Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults","volume":"21","author":"Lesprit","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0250","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/QAD.0b013e3283389de5","article-title":"Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults","volume":"24","author":"Pe\u00f1aranda","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.vaccine.2010.11.034","article-title":"Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients","volume":"29","author":"Meerveld-Eggink","year":"2011","journal-title":"Vaccine"},{"issue":"Annex2","key":"10.1016\/j.vaccine.2015.02.026_bib0260","first-page":"64","article-title":"Recommendations for the production and control of pneumococcal conjugate vaccines","volume":"927","author":"World Health Organization","year":"2005","journal-title":"WHO Tech Rep Ser"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0265","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1128\/CVI.00264-07","article-title":"Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine","volume":"14","author":"Balmer","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.02.026_bib0270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:13Z","timestamp":1759400473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X15002030"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}